title: Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells.
abstract: Autocrine transforming growth factor alpha (TGFalpha) is an important positive growth effector in malignant cells and plays a significant role in generating the growth factor-independent phenotype associated with malignant progression. However, the molecular mechanisms by which TGFalpha confers a growth advantage in progression is poorly understood. The highly tumorigenic cell line HCT116 up-regulates TGFalpha mRNA expression during growth arrest, whereas the poorly tumorigenic growth factor-dependent FET cell line down-regulates TGFalpha mRNA expression as it becomes quiescent. We have identified a 25-bp sequence at -201 to -225 within the TGFalpha promoter which mediates the differential regulation of TGFalpha expression during quiescence establishment in these two cell lines. This same sequence confers TGFalpha promoter responsiveness to exogenous growth factor or autocrine TGFalpha. The abberant upregulation of TGFalpha mRNA in quiescent HCT116 cells may allow them to return to the dividing state under more stringent conditions (nutrient replenishment alone) then quiescent FET cells (requires nutrients and growth factors). Antisense TGFalpha approaches showed that the dysregulated TGFalpha expression in quiescent HCT116 cells is a function of the strong TGFalpha autocrine loop (not inhibited by blocking antibodies) in these cells.
authors.affiliation: Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43699-0008, USA. howellg@uthscso.edu
authors.forename: G M
authors.initials: GM
authors.lastname: Howell
authors.forename: L E
authors.initials: LE
authors.lastname: Humphrey
authors.forename: R A
authors.initials: RA
authors.lastname: Awwad
authors.forename: D
authors.initials: D
authors.lastname: Wang
authors.forename: A
authors.initials: A
authors.lastname: Koterba
authors.forename: B
authors.initials: B
authors.lastname: Periyasamy
authors.forename: J
authors.initials: J
authors.lastname: Yang
authors.forename: W
authors.initials: W
authors.lastname: Li
authors.forename: J K
authors.initials: JK
authors.lastname: Willson
authors.forename: B L
authors.initials: BL
authors.lastname: Ziober
authors.forename: K
authors.initials: K
authors.lastname: Coleman
authors.forename: J
authors.initials: J
authors.lastname: Carboni
authors.forename: M
authors.initials: M
authors.lastname: Lynch
authors.forename: M G
authors.initials: MG
authors.lastname: Brattain
mesh_terms: D001483:Base Sequence; D002453:Cell Cycle / Q000502:physiology*; D002455:Cell Division; D002460:Cell Line; D015500:Chloramphenicol O-Acetyltransferase / Q000096:biosynthesis; D002999:Clone Cells; D003001:Cloning, Molecular; D003110:Colonic Neoplasms; D004815:Epidermal Growth Factor / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D015698:Genomic Library; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D007700:Kinetics; D007962:Leukocytes / Q000378:metabolism; D008969:Molecular Sequence Data; D010641:Phenotype; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000096:biosynthesis; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012045:Regulatory Sequences, Nucleic Acid; D014158:Transcription, Genetic / Q000187:drug effects; D014162:Transfection; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis* / Q000235:genetics*; D014407:Tumor Cells, Cultured
chemical_list: D007328:Insulin; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D016211:Transforming Growth Factor alpha; D004815:Epidermal Growth Factor; D015500:Chloramphenicol O-Acetyltransferase